Cargando…
Treating Multiple Myeloma in the Context of the Bone Marrow Microenvironment
The treatment landscape of multiple myeloma (MM) has evolved considerably with the FDA-approval of at least 15 drugs over the past two decades. Together with the use of autologous stem cell transplantation, these novel therapies have resulted in significant survival benefit for patients with MM. In...
Autores principales: | Ho, Matthew, Xiao, Alexander, Yi, Dongni, Zanwar, Saurabh, Bianchi, Giada |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9689284/ https://www.ncbi.nlm.nih.gov/pubmed/36421358 http://dx.doi.org/10.3390/curroncol29110705 |
Ejemplares similares
-
Exosomes in the Pathogenesis and Treatment of Multiple Myeloma in the Context of the Bone Marrow Microenvironment
por: Chen, Tianzeng, et al.
Publicado: (2020) -
Bone Marrow Microenvironment in Multiple Myeloma Progression
por: Manier, S., et al.
Publicado: (2012) -
Micro-RNAs, New performers in multiple myeloma bone marrow microenvironment
por: Abdi, Jahangir, et al.
Publicado: (2014) -
Extracellular vesicle cross-talk in the bone marrow microenvironment: implications in multiple myeloma
por: Wang, Jinheng, et al.
Publicado: (2016) -
Immune-based therapies in the management of multiple myeloma
por: Zanwar, Saurabh, et al.
Publicado: (2020)